Friday, Apr 19 2024 | Time 09:50 Hrs(IST)
image
Business EconomyPosted at: Jan 19 2022 3:44PM


Biophore India to manufacture indigenous ingredients of Pfizer’s Covid drug

Hyderabad, Jan 19 (UNI) Biophore India Pharmaceuticals announced on Wednesday that they have developed and started manufacturing the key intermediates of Nirmatrelvir, one of the active ingredients of Paxlovid, the latest anti-Covid therapy, approved by US FDA through the emergency use authorisation route.

The manufacturing is being done in collaboration with Rakshit Group. This is expected to greatly reduce the dependence on imports, mainly from China, from where these intermediates are being procured currently.

Biophore is also manufacturing Nirmatrelvir in a US FDA compliant facility and have announced that they will be filing for approval with DCGI soon.

Paxlovid’s breakthrough approval was given by the US FDA in December 2021 and is indicated for the treatment of mild-to-moderate Covid-19 in adults and paediatric patients as well and in those who are at high risk of progression to severe levels.

It was the first oral pill that has been approved by US FDA and with a better safety profile than subsequently approved oral therapies. It is available in a co-pack of Nirmatrelvir and Ritonavir Tablets.

Speaking on the occasion, Dr Jagadeesh Babu Rangisetty, CEO at Biophore, said, “The development and manufacturing of these intermediates is extremely complex and is significantly more challenging than earlier antivirals that have been indicated for COVID. We have developed the intermediates that are required for the manufacturing of this product from basic raw materials and have the manufacturing capabilities in place to produce high volumes, to the scale of multi tons, catering to Indian as well as global markets."

"As and when the product gets approved in India, we can ensure that the manufacturers of this product can be self-reliant from within India itself and not be dependent on imports, which can be tricky in terms of control of quality and supply,”he added.

Mr. Rameswara Rao Chandana, Chairman of Rakshit Group, says, “Rakshit Group’s subsidiary, Sainor Laboratories, is the largest manufacturer of Lithium HMDS in India with a capacity of 500 MT per month and has the facilities to handle cryogenic reactions. Manufacturing of these intermediates requires extreme temperatures and large volumes of Lithium reagents and with the above infrastructure that we have, we are well placed to ensure that the requirements for the market can be met locally. With a strong partner such as Biophore, we believe this is a perfect synergy to get these products to the market quickly,”
UNI VV RKM
Please log in to get detailed story.
Tags: #Biophore India to manufacture indigenous ingredients of Pfizer’s Covid drug
More News

Bajaj Auto net profit at Rs 1936 cr in Q4; clocks all-time high revenue in FY24

18 Apr 2024 | 6:46 PM

New Delhi, Apr 18 (UNI) Two wheeler auto major Bajaj Auto on Thursday announced 29 percent jump in its revenue in Q4 (January-March) at 11,485 crore, led by the broad based buoyancy that was sustained on the domestic business and aided by steady exports.

see more..

Entering share market can boost growth of SMEs: Infopark event

18 Apr 2024 | 6:31 PM

Kochi, Apr 18 (UNI) Small and marginal companies in Kerala enjoy immense scope for growth by entering the stock market, experts said at an Infopark-organised event here on Thursday.

see more..

18 Apr 2024 | 6:09 PM

New Delhi, Apr 18 (UNI) Angle One, a retail stock broking house in India, today announced 31 per cent jump in net profit at Rs 340 crore during Q4 of the last financial year over Rs 260.3 crore in the previous quarter.

see more..

Microsoft and ByteXL join hands to Present HackXcelerate 2024 at CBIT in Hyderabad

18 Apr 2024 | 5:57 PM

Hyderabad, Apr 18 (UNI) Microsoft, a global technology leader, has joined hands with ByteXL, a pioneering EdTech platform, to present HackXcelerate 2024, a nationwide hackathon aimed at igniting creativity and enhancing problem-solving skills among students.

see more..

Honda Motorcycle & Scooter India inaugurates new Engine Assembly Line for CKD exports

18 Apr 2024 | 5:46 PM

Gurugram, Apr 18 (UNI) Honda Motorcycle & Scooter India (HMSI), one of the country’s leading two-wheeler manufacturers, has announced a significant milestone in its journey.

see more..
image